Treatment of Partial Seizures in Childhood: An Overview

CNS Drugs

Volumn 18, Issue 3, 2004, Pages 133-156

  Coppola, Giangennaro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGGRESSIVENESS; ALOPECIA; ANOREXIA; ATAXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; BLOOD TOXICITY; CLINICAL TRIAL; COGNITIVE DEFECT; COMPARATIVE STUDY; DATA ANALYSIS; DIARRHEA; DIPLOPIA; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; DRUG TOLERANCE; DYSPHONIA; EPILEPTIC STATE; FATIGUE; FOCAL EPILEPSY; GAIT DISORDER; GINGIVA HYPERTROPHY; HEADACHE; HIRSUTISM; HOARSENESS; HUMAN; HYPERKINESIA; HYPERTRICHOSIS; INCREASED APPETITE; INFECTION; INSOMNIA; IRRITABILITY; KETOGENIC DIET; LEARNING DISORDER; LEUKOPENIA; LIVER TOXICITY; MEMORY DISORDER; MOOD DISORDER; MUSCLE WEAKNESS; NAUSEA; PARESTHESIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; TREATMENT FAILURE; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VAGUS NERVE STIMULATION; VISUAL DISORDER; WEIGHT GAIN;

ANTICONVULSANTS; CHILD; ELECTRIC STIMULATION THERAPY; EPILEPSIES, PARTIAL; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 1442310925     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200418030-00001     Document Type: Review

References (97)

1. Blume WT, Ociepa D, Kander V. Frontal lobe seizure propagation: scalp and subdural EEC studies. Epilepsia 2001; 42: 491-503
2. Gèrard F, Kaminska A, Plouin P, et al. Focal seizures versus focal epilepsy in infancy: a challenging distinction. Epileptic Disord 1999; 1: 135-9
3. Verity CM, Hosking G, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev Med Child Neurol 1995; 37: 97-108
4. de Silva M, MacArdle B, McGowan M, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996; 347: 709-13
5. Nieto-Barrera M, Brozmanova M, Capovilla G, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 2001; 46: 145-55
6. Zamponi N, Cardinali C. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. Arch Neurol 1999; 56: 605-7
7. Mitchell WG, Chavez JM. Carbamazepine versus phenobarbital for partial-onset seizures in children. Epilepsia 1987; 28: 56-60
8. Gobbi G, Pini A, Bertani G, et al. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies. Epilepsy Res 1999; 35: 29-37
9. Gilliam FG, Reife R, Wu SC. Topiramate monotherapy: randomised controlled trial in patients with recently diagnosed localisation-related epilepsy. Neurology 2003; 60: 196-202
10. Cross JH, Neto W, Wang S, et al. Topiramate, carbamazepine, and valproate monotherapy in children with newly diagnosed epilepsy [abstract]. Epilepsia 2001; 42 Suppl. 2: E-0331
11. Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997; 27: 205-13
12. Sachdeo RC, Edwards K, Hasegawa H, et al. Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent-onset partial epilepsy [abstract]. Neurology 1999; 52 Suppl. 2: A391
13. Schachter SC, Vazquez B, Fisher RS, et al. Oxcarbazepine: a double-blind, randomised, placebo-controlled monotherapy trial in patients with epilepsy after presurgical evaluation of refractory partial seizures. Neurology 1999; 52: 732-7
14. Beydoun A, Sachdeo RC, Rosenfeld WE, et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000; 54: 2245-51
15. Bourgeois B, Brown LW, Pellock JM, et al. Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): a 36-week, double-blind, placebo-controlled study [abstract]. Epilepsia 1998; 39 Suppl. 6: S163
16. Appleton R, Fichtner K, LaMoreaux L, et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Epilepsia 1999; 40 (8): 1147-54
17. Dalla Bernardina B, Fontana E, Vigevano F, et al. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study. Epilepsia 1995; 36: 687-91
18. Luna D, Dulac O, Pajot N, et al. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 1989; 30: 430-7
19. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 2000; 54: 2237-44
20. Sachdeo R, Glauser T, Wheles J, et al. Oxcarbazepine (Trileptal) provides additional benefits over carbamazepine as combination therapy in children with refractory partial epilepsy [abstract]. Epilepsia 2002; 43 Suppl. 8: P614
21. Duchowny M, Pellock JM, Graf WD, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology 1999; 53: 1724-31
22. Shapiro DY, Nordli D, Glauser TA, et al. Gabapentin as add-on therapy for refractory partial seizures in children 1-36 months of age: a novel, short-term, placebo-controlled trial [abstract]. Epilepsia 2000; 41 Suppl. 7: 2
23. Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomised trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999; 52: 1388-44
24. Vining EPG, Mellits ED, Dorsen MM, et al. Psychologic and behavioural effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987; 80: 165-74
25. Calandre EP, Dominguez-Granados R, Gomez-Rubio M, et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990; 81: 504-6
26. Camfield CS, Chaplin S, Doyle AB, et al. Side effects of phenobarbital in toddlers; behavioural and cognitive aspects. J Pediatr 1979; 95: 351-65
27. Riva D, Devoti M. Discontinuation of phenobarbital in children: effect on neurocognitive behaviour. Pediatr Neurol 1996; 14: 36-40
28. Wolf SM, Forsythe A, Stunden AA, et al. Long-term effect of phenobarbital on cognitive function in children with febrile convulsions. Pediatrics 1981; 68: 820-3
29. Prenx PM, Tiemagni F, Fodzo L, et al. Antiepileptic therapies in the Mifi Province in Cameroon. Epilepsia 2000; 41 (4): 432-9
30. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002; 16: 695-714
31. Shorvon S. Handbook of epilepsy treatment. Oxford: Blackwell Science, 2000
32. Verrotti A, Morresi S, Basciani F, et al. Discontinuation of anticonvulsant therapy in children with partial epilepsy. Neurology 2000; 55: 1393-5
33. Canadian Study Group for Chilhood Epilepsy. Clobazam has equivalent efficacy to carbamazepine and phenytoin as mono-therapy for childhood epilepsy. Epilepsia 1998; 39: 952-9
34. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997; 314: 180-1
35. Harding GFA. Severe persistent visual field constriction associated with vigabatrin. BMJ 1998; 316: 232-3
36. Schmitz B, Schimdt T, Jokiel B, et al. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study. J Neurol 2002; 249: 469-75
37. Vanhatalo S, Paakkonen L. Visual field constriction in children treated with vigabatrin. Neurology 1999; 52: 1713-4
38. Jannetti P, Spalice A, Perla MF, et al. Visual field constriction in children with epilepsy on vigabatrin treatment. Pediatrics 2000; 106: 838-42
39. Schlumberger E, Chavez F, Placios L, et al. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994; 35: 359-65
40. Besag FM, Wallace SJ, Dulac O, et al. Lamotrigine for the treatment of epilepsy in childhood. J Pediatrics 1995; 27: 991-7
41. Biton V, Montouris GD, Ritter F, et al. A randomised placebo-controlled study of topiramate in primary generalised tonic-clonic seizures. Neurology 1999; 52: 1330-7
42. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomised trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group. Neurology 1999; 52: 1882-7
43. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998; 39: 1324-8
44. Ritter F, Glauser TA, Elterman RD, et al. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures: Topiramate YP Study Group. Epilepsia 2000; 41 Suppl. 1: S82-5
45. Glauser T, Sachdeo R, Bebin M, et al. Two years long-term safety and efficacy of oxcarbazepine (Trileptal) in children with refractory partial seizures [abstract]. Epilepsia 2002; 43 Suppl. 8: P615
46. Appleton R, Fichtner K, LaMoreaux L, et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study. Dev Med Child Neurol 2001; 43: 269-73
47. Glauser TA, Pellock JM, Bebin EM, et al. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia 2002; 43: 518-24
48. Wheless JW. Levetiracetam in refractory paediatric epilepsy. J Child Neurol 2002; 17: 413-5
49. Kosoff EH, Bergey GK, Freeman JM, et al. Levetiracetam psychosis in children with epilepsy. Epilepsia 2001; 42: 1611-3
50. Helmholz HF. Treatment of epilepsy in childhood: five years experience with ketogenic diet. JAMA 1927; 88: 2028
51. Carmant L, Holmes GL, Sawyer S, et al. Efficacy of felbamate in therapy for partial epilepsy in children. J Pediatr 1994; 125: 481-6
52. Avanzini G, Canger R, Dalla Bernardina B, et al. Felbamate in therapy-resistant epilepsy: an Italian experience: Felbamate Italian Study Group. Epilepsy Res 1996; 25: 249-55
53. Cilio MR, Karstashow AI, Vigevano F. The long-term use of felbamate in children with severe refractory epilepsy. Epilepsy Res 2001; 47: 1-7
54. Pellock JM. Felbamate. Epilepsia 1999; 40 Suppl. 5: S57-62
55. Shinnar S. Tiagabine. Semin Pediatr Neurol 1997; 4: 24-33
56. Gustavson LE, Boellner SW, Granneman GR, et al. A single-dose study to define tiagabine pharmacokinetics in paediatric patients with complex partial seizures. Neurology 1997; 48: 1032-7
57. Uldall P, Bulteau C, Pedersen SA, et al. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study. Epilepsy Res 2000; 42: 159-68
58. Shuto H, Sugimoto T, Yasuhara A, et al. Efficacy of zonisamide in children with refractory partial seizures. Curr Ther Res 1989; 45: 1031-6
59. Hosoda N, Miura H, Takanashi S, et al. Clinical efficacy and blood concentration with once-daily zonisamide monotherapy in paediatric patients with partial seizures. TDM Kenkyu 1993; X: 240-1
60. Hosoda N, Miura H, Takanashi S, et al. Clinical effects and blood concentrations of zonisamide in epileptic children with partial seizures treated with a once-daily dose of zonisamide monotherapy [abstract]. Jpn J Ther Drug Monit 1994; O-18: 68
61. Hosoda N, Miura H, Takanashi S, et al. Once-daily dose of zonisamide monotherapy in the control of partial seizures in children with cryptogenic localisation-related epilepsies: clinical effects and their pharmacokinetic basis. Jpn J Psychiatry Neurol 1994; 48: 335-7
62. Kumagai N, Seki T, Yamakawa H, et al. Monotherapy for childhood epilepsies with zonisamide. Jpn J Psychiatry Neurol 1991; 45: 357-9
63. Hayakawa T, Nejihashi Y, Kishi T, et al. Serum zonisamide concentration in fresh cases of childhood epilepsy following zonisamide monotherapy. J Jpn Epilepsy Soc 1994; 12: 249-54
64. Fukushima K, Yagi K, Seino M, et al. Phase II clinical trial of a new antiepileptic drug, zonisamide (ZNA) in paediatric epilepsy patients. Jpn J Pediatr 1987; 40: 3389-97
65. Kanazawa K, Segoku A, Kawai I. A clinical trial of zonisamide, a new antiepileptic drug, on adults and children with refractory epilepsy. J Clin Ther Med 1987; 3: 1181-6
66. Takahashi I, Yamamoto N, Furune S, et al. Efficacy of zonisamide for intractable epilepsy in childhood. J Jpn Epilepsy Soc 1987; 5: 100-5
67. Tagawa T, Mimaki T, Yabuuki H, et al. Treatment of childhood epilepsies with zonisamide (Ad-810). J Pediatr Pract 1988; 51: 539-43
68. Oguni H, Hayakawa T, Fukuyama Y. Clinical trial of zonisamide, a new antiepileptic drug, in cases of refractory childhood epilepsy. J Jpn Epilepsies Soc 1989; 7: 43-50
69. Oguni H, Hayakawa T, Fukuyama Y, et al. Phase III clinical study of the new antiepileptic drug AD-810 (zonisamide) in patients with childhood epilepsy. Jpn J Pediatr 1988; 41: 439-50
70. Suzuki N, Seki T, Yamawaki H, et al. Therapy of partial epilepsy with AD-810 (zonisamide). Jpn J Pediatr 1987; 40: 3147-52
71. Sakamoto K, Kurokawa T, Tomita S, et al. Effects of zonisamide on children with epilepsy. Curr Ther Res 1988; 13: 378-83
72. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc 1921; 2: 307-8
73. Wilkins L. Epilepsy in childhood: III. Results with the ketogenic diet. J Pediatr 1937; 10: 341-57
74. Coppola G, Veggiotti P, Cusmai R, et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res 2002; 48: 221-7
75. Freeman JM, Freeman JB, Kelly MT. The ketogenic diet: a treatment for epilepsy. New York: Demos Publications, 2000
76. Wheless JW. The ketogenic diet: an effective medical therapy with side effects. J Child Neurol 2001; 16: 633-5
77. Livingston S. Dietary treatment of epilepsy. In: Livingston S, editor. Comprehensive management of epilepsy in infancy, childhood and adolescence. Springfield (IL): Charles C. Thomas, 1972: 378-405
78. Kinsman SL, Vining EPG, Quaskey SA, et al. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 1992; 33 (6): 1132-6
79. Freeman J, Vining E, Pillas D, et al. The efficacy of the ketogenic diet: 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998; 102: 1358-63
80. Casey JC, McGrogan J, Pillas D, et al. The implementation and maintenance of the ketogenic diet in children. J Neurosci Nurs 1999; 31: 294-302
81. Vining EPG. Clinical efficacy of the ketogenic diet. Epilepsy Res 1999; 37: 181-90
82. Kaytal NG, Koehler AN, McGhee B, et al. The ketogenic diet in refractory epilepsy: the experience of Children's Hospital of Pittsburgh. Clin Pediatr 2000; 39: 153-9
83. LeFevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy [abstract]. Pediatrics 2000; 105 (4): E46
84. Magrath G, MacDonald A, Whitehouse W. Dietary practices and use of the ketogenic diet in the UK. Seizure 2000; 9: 128-30
85. Maydell BV, Wyllie E, Akhtar N, et al. Efficacy of the ketogenic diet in focal versus generalised seizures. Pediatr Neurol 2001; 25: 208-12
86. Hemingway C, Freeman JM, Pillas DJ, et al. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001; 108: 898-905
87. Handforth A, De Giorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomised active-control trial. Neurology 1998; 51: 48-55
88. Zamponi N, Rychlicki F, Cardinali C, et al. Intermittent vagal nerve stimulation in paediatric patients: 1-year follow-up. Childs Nerv Syst 2002; 18: 61-6
89. Murphy JV. Left vagal nerve stimulation in children with medically refractory epilepsy. J Pediatr 1999; 134: 563-6
90. Renfroe JB, Wheles JW. Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy. Neurology 2002; 59 Suppl. 4: S26-30
91. Ambrosetto G, Tassinari CA. Antiepileptic drug treatment of benign childhood epilepsy with rolandic spikes: is it necessary? Epilepsia 1990; 31: 802-5
92. Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998; 39 Suppl. 3: S2-10
93. Aso K, Watanabe K. Limitations in the medical treatment of cryptogenic or symptomatic localisation-related epilepsies of childhood onset. Epilepsia 2000; 41 Suppl. 9: 18-20
94. Britton JW, So EL. Selection of antiepileptic drugs: a practical approach. Mayo Clin Proc 1996; 71: 778-86
95. Guerrini R, Battini R, Ferari AR, et al. The costs of childhood epilepsy in Italy: comparative findings from three health care settings. Epilepsia 2001; 42: 641-6
96. Rambek B, Salke-Treumann A, May T, et al. Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents. Eur Neurol 1990; 30 (2): 79-83
97. Duchowny M. Pediatric epilepsy surgery: the widening spectrum of surgical candidacy. Epileptic Disord 1999; 1: 143-51